Standards of medical care in diabetes 2010
Open accessThe DOI matches its Crossref record; 437 of the 437 references it cites were found in a registry or an index.
Abstract
D iabetes is a chronic illness that requires continuing medical care and ongoing patient self-management education and support to prevent acute complications and to reduce the risk of long-term complications. Diabetes care is complex and requires that many issues, beyond glycemic control, be addressed. A large body of evidence exists that supports a range of interventions to improve diabetes outcomes. These standards of care are intended to provide clinicians, patients, researchers, payors, and other interested individuals with the components of diabetes care, general treatment goals, and tools to evaluate the quality of care. While individual preferences, comorbidities, and other patient factors may require modification of goals, targets that are desirable for most patients with diabetes are provided. These standards are not intended to preclude clinical judgment or more extensive evaluation and management of the patient by other specialists as needed. For more detailed information about management of diabetes, refer to references 1–3. The recommendations included are screening, diagnostic, and therapeutic actions that are known or believed to favorably affect health outcomes of patients with diabetes. A grading system (Table 1), developed by the American Diabetes Association (ADA) and modeled after existing methods, was used to clarify and codify the evidence that forms the basis for the recommendations. The level of evidence that supports each recommendation is listed after each recommendation using the letters A, B, C, or E. These standards of care are revised annually by the ADA multidisciplinary Professional Practice Committee, and new evidence is incorporated. Members of the Professional Practice Committee and their disclosed conflicts of interest are listed in the Introduction. Subsequently, as with all position statements, the standards of care are reviewed and approved by the Executive Committee of ADA’s Board of Directors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The finding for diabetes was also unchanged when a cutoff for glycated hemoglobin of 6.5% or more was used in local analysis, consistent with the 2010 ADA recommendation30 (hazard ratio, 0.49; 95% CI, 0.38 to 0.64).”
From Pioglitazone after Ischemic Stroke or Transient Ischemic Attack (2016) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Group based training for self-management strategies in people with type 2 diabetes mellitus
Deakin, T. A., McShane, C. E., Cade, J. E., & Williams, R. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003417.pub2 · Cited by 862
RetractedToprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
Research works printed but not linked: 9
- American Diabetes Asociation Medical Management of Type 1 Diabetes. Alexandria, VA, American Diabetes Association, 2008
- Heisler M: Building Peer Support Programs to Manage Chronic Disease: Seven Models for Success. Oakland, CA, California Health Care Foundation, 2006
- Aiello LP Wong J Cavallerano J Bursell SE Aiello LM: Retinopathy. In Handbook of Exercise in Diabetes. 2nd ed. Ruderman N Devlin JT Kriska A: Eds. Alexandria, VA, American Diabetes Association, 2002, p. 401– 413
- Vinik A Erbas T: Neuropathy. In Handbook of Exercise in Diabetes. 2nd ed. Ruderman N Devlin JT Kriska A: Eds. Alexandria, VA, American Diabetes Association, 2002, p. 463– 496
- Mogensen CE: Nephropathy. In Handbook of Exercise in Diabetes. 2nd ed. Ruderman N Devlin JT Kriska A: Eds. Alexandria, VA, American Diabetes Association, 2002, p. 433– 449
- American Diabetes Association: Psychosocial factors affecting adherence, quality of life, and well-being: Helping Patients cope. In Medical Management of Type 1 Diabetes. 5 ed. Francine R Kaufman: Ed. Alexandria, VA, American Diabetes Association, 2008, p. 173– 193
- Baigent C Keech A Kearney PM Blackwell L Buck G Pollicino C Kirby A Sourjina T Peto R Collins R Simes R: Cholesterol Treatment Trialists' (CTT) Collaborators Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005; 366: 1267– 1278 16214597 · DOI · Paper page
- Buse JB Ginsberg HN Bakris GL Clark NG Costa F Eckel R Fonseca V Gerstein HC Grundy S Nesto RW Pignone MP Plutzky J Porte D Redberg R Stitzel KF Stone NJ: American Heart Association, American Diabetes Association Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care 2007; 30: 162– 172 17192355 · DOI · Paper page
- US Preventive Services Task Force Counseling to Prevent Tobacco Use and Tobacco-Related Diseases: Recommendation Statement. Rockville, MD, Agency for Healthcare Research and Quality, 2003
Cited by
Items 601–700 of 1,022
Insulin treatment for type 2 diabetes: When to start, which to use
Hamaty, M. (2011) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.78a.10051 · Cited by 65
Fasting Plasma Glucose and Hemoglobin A1c in Identifying and Predicting Diabetes
Wang, W., Lee, E. T., Howard, B. V., Fabsitz, R. R., Devereux, R. B., & Welty, T. K. (2011) · Diabetes Care · doi:10.2337/dc10-1680 · Cited by 55
Frei, A. L., Senn, O., Chmiel, C., Reissner, J., Held, U., & Rosemann, T. J. (2014) · Diabetes Care · doi:10.2337/dc13-1429 · Cited by 60
Mostafa, S. A., Davies, M. J., Srinivasan, B. T., Carey, M., Webb, D. R., & Khunti, K. (2010) · Postgraduate Medical Journal · doi:10.1136/pgmj.2009.091215 · Cited by 58
Cheung, C., Cheung, T. T., Lam, K. S. L., & Cheung, B. M. Y. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2012.11.024 · Cited by 60
Yang, B., Chen, Y., Xu, T., Yu, Y., Huang, T., Hu, X., & Li, D. (2011) · PubMed · Cited by 74
Management of diabetes mellitus in the elderly
Chiniwala, N., & Jabbour, S. A. (2011) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283444ba0 · Cited by 63
CF‐related diabetes: Containing the metabolic miscreant of cystic fibrosis
Moheet, A. A., & Moran, A. (2017) · Pediatric Pulmonology · doi:10.1002/ppul.23762 · Cited by 62
Shuaib, M., Ahmed, S., Ali, K., Ilyas, M., Hussain, F., Urooj, Z., Shah, S. S., Kumar, T., Shah, M., Khan, I., et al. (2018) · Acta Ecologica Sinica · doi:10.1016/j.chnaes.2018.04.006 · Cited by 55
Biological variability of glycated hemoglobin
Braga, F., Dolci, A., Mosca, A., & Panteghini, M. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.07.030 · Cited by 62
Noninvasive glucose detection in exhaled breath condensate
Tankasala, D., & Linnes, J. C. (2019) · Translational research · doi:10.1016/j.trsl.2019.05.006 · Cited by 55
Prevalence of diagnosed diabetes in American Indian and Alaska Native adults, 2006–2017
Bullock, A. K., Sheff, K. L., HORA, I. A., Burrows, N. R., Benoit, S. R., Saydah, S., Hardin, C. L., & Gregg, E. W. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001218 · Cited by 55
“In addition, national guidelines were revised in 2010 to include the HbA 1c test as an option for diagnosing diabetes, 32 though it has been shown to be less sensitive than the other accepted tests.”
Or, C. K., Holden, R. J., & Valdez, R. S. (2022) · Automation, collaboration, and e-services · doi:10.1007/978-3-031-10788-7_6 · Cited by 66
Carlsen, S., Petersen, P. H., Skeie, S., Skadberg, Ø., & Sandberg, S. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.233 · Cited by 58
Sultan, S., Luminet, O., & Hartemann, A. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.09.022 · Cited by 54
Assessment of HbA1c as a diagnostic tool in diabetes and prediabetes
Tankova, T. I., Chakarova, N. Y., Dakovska, L. N., & Atanassova, I. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0334-5 · Cited by 61
Williams, L. B., Sattin, R. W., Dias, J., Garvin, J. T., Marion, L., Joshua, T., Kriska, A., Kramer, M. K., Echouffo-Tcheugui, J. B., Freeman, A., et al. (2013) · Contemporary Clinical Trials · doi:10.1016/j.cct.2013.01.002 · Cited by 52
Braga, F., Dolci, A., Montagnana, M., Pagani, F., Paleari, R., Guidi, G. C., Mosca, A., & Panteghini, M. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.04.014 · Cited by 57
Late‐Life Factors Associated with Healthy Aging in Older Men
Bell, C., Chen, R., Masaki, K., Yee, P., He, Q., Grove, J., Donlon, T. A., Curb, J. D., Willcox, D. C., Poon, L. W., et al. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12796 · Cited by 58
Bardenheier, B. H., Bullard, K. M., Caspersen, C. J., Cheng, Y. J., Gregg, E. W., & Geiss, L. S. (2013) · Diabetes Care · doi:10.2337/dc12-2608 · Cited by 67
Trends in the Prevalence of Coronary Heart Disease in the U.S.
Yoon, S. S. (., Dillon, C. F., Illoh, K., & Carroll, M. (2016) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2016.02.023 · Cited by 53
The Relationship of Glycemic Control to the Outcomes of Dental Extractions
Aronovich, S., Skope, L. W., Kelly, J. P. W., & Kyriakides, T. C. (2010) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2010.05.006 · Cited by 53
Serum C-reactive protein level and prediabetes in two Asian populations
Sabanayagam, C., Shankar, A., Lim, S. C., Lee, J., Tai, E. S., & Wong, T. Y. (2011) · Diabetologia · doi:10.1007/s00125-011-2052-5 · Cited by 58
Rathmann, W., Kowall, B., Tamayo, T., Giani, G., Holle, R., Thorand, B., Heier, M., Huth, C., & Meisinger, C. (2012) · Annals of Medicine · doi:10.3109/07853890.2010.531759 · Cited by 51
Do low testosterone levels contribute to ill-health during male ageing?
Yeap, B. B., de Araújo, A. B., & Wittert, G. (2012) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2012.725461 · Cited by 53
Povel, C. M., Boer, J. M. A., Onland‐Moret, N. C., Dollé, M. E. T., Feskens, E. J. M., & van der Schouw, Y. T. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-133 · Cited by 59
Glucose intolerance, metabolic syndrome, and neuropathy
Cortez, M. M., Singleton, J. R., & Smith, A. G. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53480-4.00009-6 · Cited by 61
Mourad, G., Głyda, M., Albano, L., Viklický, O., Merville, P., Tydén, G., Mourad, M., Lõhmus, A., Witzke, O., Christiaans, M. H. L., et al. (2016) · Transplantation · doi:10.1097/tp.0000000000001453 · Cited by 53
Relation of Dysglycemia to Structural Brain Changes in a Multiethnic Elderly Cohort
Reitz, C., Guzman, V. A., Narkhede, A., DeCarli, C. S., Brickman, A. M., & Luchsinger, J. A. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14551 · Cited by 56
DPP-4 Inhibitors as Treatments for Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis
Wang, Q., Long, M., Qu, H., Shen, R., Zhang, R., Xu, J., Xiong, X., Wang, H., & Zheng, H. (2018) · Journal of Diabetes Research · doi:10.1155/2018/5308582 · Cited by 59
“The proportion of diabetes mellitus patients diagnosed with T1DM is estimated to be 5%–10% [1] with an annual increase of 3.”
BackgroundMolecular mechanisms for insulin resistance in treated HIV-infection
Hruz, P. W. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.10.017 · Cited by 60
Use of Complementary and Alternative Medicine Supplements in Patients with Diabetes Mellitus
Fabian, E., Töscher, S., Elmadfa, I., & Pieber, T. R. (2011) · Annals of Nutrition and Metabolism · doi:10.1159/000326765 · Cited by 57
Limited utility of oral glucose tolerance test in biochemically active acromegaly
Ribeiro‐Oliveira, A., Faje, A. T., & Barkan, A. L. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0744 · Cited by 53
Chatzimarkakis, J. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400634 · Cited by 67
Resting heart rate and risk of type 2 diabetes: A prospective cohort study and meta-analysis
Lee, D. H., de Rezende, L. F. M., Hu, F. B., Jeon, J. Y., & Giovannucci, E. L. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3095 · Cited by 52
Fang, L., Sheng, H., Tan, Y., & Zhang, Q. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1088882 · Cited by 52
Wang, H., Guo, Z., & Xu, Y. S. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03425-4 · Cited by 61
Multidrug Treatment of Type 2 Diabetes
Miccoli, R., Penno, G., & Del Prato, S. (2011) · Diabetes Care · doi:10.2337/dc11-s235 · Cited by 52
Retnakaran, R. R., Qi, Y., Connelly, P. W., Sermer, M., Hanley, A. J., & Zinman, B. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03834.x · Cited by 57
Hemoglobin A1c measurement for the diagnosis of Type 2 diabetes in children
Drugs and Therapeutics Committee of the Pediatric Endocrine Society, Kapadia, C., & Zeitler, P. (2012) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2012-31 · Cited by 50
Adair, R., Wholey, D. R., Christianson, J. B., White, K. M., Britt, H. R., & Lee, S. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-3-201308060-00007 · Cited by 55
Effect of local insulin injection on wound vascularization in patients with diabetic foot ulcer
Zhang, Z.-X., & LV, L. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2917 · Cited by 52
Curreri, C., Giantin, V., Veronese, N., Trevisan, C., Sartori, L., Musacchio, E., Zambon, S., Maggi, S., Perissinotto, E., Corti, M. C., et al. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07334 · Cited by 54
“1 nmol/L.(17) Hypertension was defined as a systolic BP ≥140 mm Hg, a diastolic BP ≥90 mm Hg, or ongoing use of antihypertensive medication.”
BackgroundSarafidis, P. A., Sharpe, C. C., Wood, E., Blacklock, R., Rumjon, A., Al-Yassin, A., Ariyanayagam, R., Simmonds, S., Fletcher-Rogers, J., & Vinen, K. (2012) · Nephron Clinical Practice · doi:10.1159/000337571 · Cited by 49
Continuous Glucose Monitoring in Insulin-Treated Patients in Non-ICU Settings
Gomez, A. M., & Umpierrez, G. E. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814546025 · Cited by 51
Selvin, E., Rawlings, A. M., Bergenstal, R. M., Coresh, J., & Brancati, F. L. (2013) · Diabetes Care · doi:10.2337/dc12-2715 · Cited by 51
Targeting metabolic syndrome: Candidate natural agents
Xia, X., & Weng, J. (2010) · Journal of Diabetes · doi:10.1111/j.1753-0407.2010.00090.x · Cited by 55
Prevalence of dyslipidemia in adult Indian diabetic patients: A cross sectional study (SOLID)
Vasnawala, H., Mithal, A., Majhi, D., Shunmugavelu, M., Talwarkar, P., & Raza, A. (2014) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.139220 · Cited by 51
Psychosocial support for people with diabetes: past, present and future
Barnard, K. D., Peyrot, M. F., & Holt, R. I. G. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03727.x · Cited by 53
Idiculla, J. M., D'Souza, Ravindran, G. D., & Singh, S. (2011) · International Journal of General Medicine · doi:10.2147/ijgm.s15818 · Cited by 51
Higashiyama, A., Okamura, T., Watanabe, M., Kokubo, Y., Wakabayashi, I., Okayama, A., & Miyamoto, Y. (2012) · Hypertension Research · doi:10.1038/hr.2012.133 · Cited by 55
The Sasang Constitutional Types Can Act as a Risk Factor for Hypertension
Lee, J., Lee, J., Lee, E., Yoo, J.-H., Kim, Y.-H., & Koh, B. (2011) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2011.561901 · Cited by 51
Sevket, O., Ates, S., Uysal, O., Molla, T., Dansuk, R., & Kelekci, S. (2014) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2013.799656 · Cited by 49
Qiao, Y., Tinker, L., Olendzki, B. C., Hébert, J. R., Balasubramanian, R., Rosal, M. C., Hingle, M. D., Song, Y., Schneider, K. L., Liu, S., et al. (2013) · Ethnicity and Health · doi:10.1080/13557858.2013.797322 · Cited by 52
Gellad, W. F., Zhao, X., Thorpe, C. T., Mor, M. K., Good, C. B., & Fine, M. J. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.5405 · Cited by 50
McCorry, N., Hughes, C., Spence, D., Holmes, V. A., & Harper, R. (2012) · Journal of Midwifery & Women s Health · doi:10.1111/j.1542-2011.2011.00143.x · Cited by 51
Hunt, L. M., Kreiner, M., & Brody, H. (2012) · The Annals of Family Medicine · doi:10.1370/afm.1380 · Cited by 38
Han, X., Li, Y., Wang, J., Liu, B., Hu, H., Li, X., YANG, K. Y., Yuan, J., Yao, P., Wei, S., et al. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2677 · Cited by 61
“We also assessed the association between H. pylori infection and type 2 diabetes risk according to diabetes diagnosis standard of the HbA1c test with a threshold of ≥6.5%, which is affirmed and recommended by American Diabetes Association [14], and the results were consistent after full adjustment [OR, 1.07 (95% CI: 1…”
BackgroundMethodInfluentialKwon, C.-H., Rhee, E., Song, J., Kim, J.-T., Kwag, H. J., & Sung, K. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-38 · Cited by 52
Liraglutide (victoza): the first once-daily incretin mimetic injection for type-2 diabetes.
Jackson, S., Martin, T. S., Jones, J. D., Seal, D., & Emanuel, F. S. (2010) · PubMed · Cited by 74
Testa, M. A., Gill, J., Su, M., Turner, R. R., Blonde, L., & Simonson, D. C. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1763 · Cited by 50
Transition From Intravenous to Subcutaneous Insulin
Avanzini, F., Marelli, G., Donzelli, W., Busi, G., Carbone, S., Bellato, L., Colombo, E. L., Foschi, R., Riva, E., Roncaglioni, M. C., et al. (2011) · Diabetes Care · doi:10.2337/dc10-2023 · Cited by 50
An overview of management issues in adult patients with type 2 diabetes mellitus
Vigersky, R. A. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500207 · Cited by 50
Viscoli, C. M., Brass, L. M., Carolei, A., Conwit, R., Ford, G. A., Furie, K. L., Gorman, M., Guarino, P. D., Inzucchi, S. E., Lovejoy, A. M., et al. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.07.016 · Cited by 50
Lee, P., Chang, A., Blaum, C., Vlajnic, A., Gao, L., & Halter, J. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03773.x · Cited by 50
Association of Metabolic Syndrome With Neuroimaging and Cognitive Outcomes in the UK Biobank
Qureshi, D., Topiwala, A., Abid, S. U. A., Allen, N. E., Kuźma, E., & Littlejohns, T. J. (2024) · Diabetes Care · doi:10.2337/dc24-0537 · Cited by 53
Sabanayagam, C., Khoo, E. Y. H., Lye, W. K., Ikram, M. K., Lamoureux, E. L., Cheng, C. Y., Tan, M. L. S., Salim, A., Lee, J., Lim, S.-C., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2498 · Cited by 48
Pan, J., Qu, H., Rentfro, A. R., McCormick, J. B., Fisher‐Hoch, S. P., & Fallon, M. B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021515 · Cited by 50
What is the Evidence for Pharmaceutical Patient Assistance Programs?: A Systematic Review
Felder, T. M., Palmer, N. R., Lal, L. S., & Mullen, P. D. (2011) · Journal of Health Care for the Poor and Underserved · doi:10.1353/hpu.2011.0003 · Cited by 50
Rutter, M. K., & Nesto, R. W. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr154 · Cited by 58
Yığıt, S., Karakuş, N., & İnanır, A. (2013) · PubMed Central · Cited by 50
Šumarac-Dumanović, M., Jeremić, D., Pantovic, A., Janjetović, K., Stamenkovic-Pejkovic, D., Cvijović, G., Stevanović, D., Micić, D., & Trajković, V. (2013) · Immunobiology · doi:10.1016/j.imbio.2013.03.002 · Cited by 53
Huang, Z., Chen, C., Li, S., Kong, F., Shan, P., & Huang, W. (2016) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2015.0255 · Cited by 53
“Prediabetes, including impaired fasting glucose (IFG) or/and impaired glucose tolerance (IGT), was diagnosed according to the 2010 American Diabetes Association criteria (American Diabetes Association, 2010).”
Diabetes, Kidney Disease, and Cardiovascular Outcomes in the Jackson Heart Study.
Afkarian, M., Katz, R., Bansal, N., Correa, A., Kestenbaum, B., Himmelfarb, J., de Boer, I., & Young, B. (2016) · American Society of Nephrology. Clinical Journal · doi:10.2215/cjn.13111215 · Cited by 46
Xu, T., He, Y., Dainelli, L., Yu, K., Detzel, P., Silva-Zolezzi, I., Volger, S., & Fang, H. (2017) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-017-1353-1 · Cited by 48
Nichols, G. A., & Moler, E. J. (2010) · Diabetologia · doi:10.1007/s00125-010-1965-8 · Cited by 52
Park, S., Kim, D.-G., Suh, G. Y., Kang, J. G., Ju, Y.-S., Lee, Y.-J., Park, J. Y., Lee, S. W., & Jung, K.-S. (2012) · Critical Care · doi:10.1186/cc11674 · Cited by 47
Potential role of non‐insulin adjunct therapy in Type 1 diabetes
George, P., & McCrimmon, R. J. (2013) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03744.x · Cited by 51
Pajunen, P., Peltonen, M., Eriksson, J. G., Ilanne‐Parikka, P., Aunola, S., Keinanen-Kiukaanniemi, S. M., Uusitupa, M. I. J., Tuomilehto, J., Lindström, J., & (DPS), F. T. F. D. P. S. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03183.x · Cited by 60
Aitken-Saavedra, J., Ortiz, C., Morales‐Bozo, I., Alcayaga, G. R., Baeza, M., Beltrán, C. J., & Escobar, A. F. (2015) · Disease Markers · doi:10.1155/2015/128653 · Cited by 49
Lunati, M. E., Grancini, V., Agnelli, F., Gatti, S., Masserini, B., Zimbalatti, D., Pugliese, G., Rossi, G. E., Donato, M. F., Colombo, M., et al. (2013) · Digestive and Liver Disease · doi:10.1016/j.dld.2013.03.009 · Cited by 49
Kato, K., Takeshita, Y., Misu, H., Zen, Y., Kaneko, S., & Takamura, T. (2015) · Journal of Diabetes Investigation · doi:10.1111/jdi.12271 · Cited by 48
Gavin, J. R., Fox, K. M., & Grandy, S. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-533 · Cited by 53
Hurst, C. P., Thinkhamrop, B., & Tran, H. T. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.5.395 · Cited by 62
Su, G., Mi, S.-H., Li, Z., Tao, H., Yang, H.-X., & Zheng, H. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-33 · Cited by 49
Aldhoon-Hainerová, I., Zamrazilová, H., Dušátková, L., Sedláčková, B., Hlavatý, P., Hill, M., Hampl, R., Kunešová, M., & Hainer, V. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-100 · Cited by 55
Saçan, Ö., Türkyılmaz, İ. B., Bayrak, B. B., Mutlu, O., Akev, N., & Yanardağ, R. (2016) · BioMetals · doi:10.1007/s10534-016-9911-y · Cited by 49
von Düring, M. E., Jenssen, T. G., Bollerslev, J., Åsberg, A., Godang, K., & Hartmann, A. (2016) · Clinical Transplantation · doi:10.1111/ctr.12869 · Cited by 50
Can Secure Patient-Provider Messaging Improve Diabetes Care?
Chung, S., Panattoni, L. E., Chi, J., & Palaniappan, L. P. (2017) · Diabetes Care · doi:10.2337/dc17-0140 · Cited by 51
Pharmacological therapy of acute ischaemic stroke: Achievements and problems
Moretti, A., Ferrari, F., & Villa, R. F. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.06.004 · Cited by 54
Vincent, D., McEwen, M. M., Hepworth, J. T., & Stump, C. S. (2013) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721713475842 · Cited by 49
Acute and Chronic Adverse Outcomes of Type 1 Diabetes
LONGENDYKE, R. L., Grundman, J., & Majidi, S. (2023) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2023.09.004 · Cited by 53
Buehler, A. M., Cavalcanti, A. B., Berwanger, O., Figueiro, M., Laranjeira, L. N., Zazula, A. D., Kioshi, B., Bugano, D. G., Santucci, E., Sbruzzi, G., et al. (2013) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2011.00308.x · Cited by 50
Managing diabetes in cystic fibrosis
Laguna, T. A., Nathan, B. M., & Moran, A. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01250.x · Cited by 48
Giordano, R., Marzotti, S., Berardelli, R., Karamouzis, I., Brozzetti, A., D'Angelo, V., Mengozzi, G., Mandrile, G., Giachino, D., Migliaretti, G., et al. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04439.x · Cited by 47
Shrank, W. H., Choudhry, N. K., Liberman, J. N., & Brennan, T. A. (2011) · Health Affairs · doi:10.1377/hlthaff.2010.0431 · Cited by 48
Green, A. J., Fox, K. M., & Grandy, S. (2010) · Journal of Obesity · doi:10.1155/2011/172073 · Cited by 54
“Respondents completed the SF-12 quality-of-life survey one year later.”
BackgroundMethodOsteocalcin as a marker of metabolic risk in healthy postmenopausal women
García-Martín, A., Cortés-Berdonces, M., Luque-Fernández, I., Rozas-Moreno, P., Quesada-Charneco, M., & Muñoz-Torres, M. (2011) · Menopause · doi:10.1097/gme.0b013e3181f8565e · Cited by 45
Remor, A. P., Matos, F., Ghisoni, K., da Silva, T. L., Eidt, G., Burigo, M. O., Bem, A. F. D., Silveira, P. C. L., de León, A., Sanchez, M. C., et al. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.06.017 · Cited by 57
Individualized glycaemic targets and pharmacotherapy in type 2 diabetes
Bailey, C. J., Aschner, P. J., Prato, S. D., LaSalle, J. R., Ji, L., Matthaei, S., & Management, O. B. O. T. G. P. F. E. D. (2013) · Diabetes and Vascular Disease Research · doi:10.1177/1479164113490765 · Cited by 51
Metadata
- Authors
- American Diabetes Association
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-01-01
- Volume
- 33
- Issue
- Supplement_1
- Pages
- S11-S61
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2797382
- OpenAlex
- W2596624061
- Cited by
- 3,470
- References
- 434
- Citations by year
- 2026: 55 · 2025: 71 · 2024: 101 · 2023: 121 · 2022: 113 · 2021: 168 · 2020: 130 · 2019: 140 · 2018: 143 · 2017: 140 · 2016: 193 · 2015: 233 · 2014: 255 · 2013: 284 · 2012: 372
- FWCI
- 301.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- diabetes mellitus, diabetes management, glycemic control, diabetes complications
- MeSH terms
- Diabetes Mellitus, Humans, Physicians, Risk Factors, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.